Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE Study.
ONCOLOGIST（2019）
关键词
Early breast cancer,Adjuvant chemotherapy,Estrogen receptor positive,Recurrence Score,21-gene assay,Oncotype DX,Treatment change,Decision impact
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要